Epidemiology of gout: an update, Best Pract Res Clin Rheumatol, vol.24, issue.6, pp.811-838, 2010. ,
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis, Rheumatol Ther, vol.3, issue.1, pp.53-75, 2016. ,
Prevalence of Gout in the Adult Population of France, Arthritis Care Res. févr, vol.68, issue.2, pp.261-267, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01187430
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review, J Rheumatol, vol.44, issue.3, pp.388-96, 2017. ,
Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men, Am J Clin Nutr, vol.87, issue.5, pp.1480-1487, 2008. ,
The management of hyperuricemia with urate deposition, Curr Med Res Opin, vol.31, issue.2, pp.27-32, 2015. ,
The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors, J Rheumatol Suppl, vol.92, pp.15-25, 2014. ,
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy, Nucleosides Nucleotides Nucleic Acids, vol.27, issue.6, pp.585-91, 2008. ,
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN), Nat Rev Rheumatol, vol.13, issue.9, pp.561-569, 2017. ,
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.65, issue.10, pp.1312-1336, 2006. ,
updated EULAR evidence-based recommendations for the management of gout, Ann Rheum Dis, 2016. ,
Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study, Ann Rheum Dis, vol.59, issue.7, pp.539-582, 2000. ,
Update on Importance of Diet in Gout, Am J Med, vol.129, issue.11, pp.1153-1161, 2016. ,
The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study, BMJ, vol.357, p.1794, 2017. ,
GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003), Joint Bone Spine Rev Rhum, vol.79, issue.5, pp.464-70, 2012. ,
GOSPEL 2-Colchicine for the treatment of gout flares in France-a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age, Joint Bone Spine Rev Rhum, vol.83, issue.6, pp.687-93, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01282350
Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century-comparison with 2006 EULAR Recommendations, Joint Bone Spine Rev Rhum, vol.3, issue.4, pp.447-53, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01616224
, World Health Organization, Organization WH. Global Status Report on Alcohol and Health, vol.389, 2014.
Analyses factorielles simples et multiples ; objectifs, méthodes et interprétation. Paris: Dunod, vol.318, 2008. ,
Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006. Obes Silver Spring Md, vol.16, pp.2182-2188, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00292589
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study, BMJ, vol.336, issue.7639, pp.309-321, 2008. ,
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations, Ann Rheum Dis, vol.66, issue.10, pp.1311-1316, 2007. ,
Prevalence of comorbidities and management of gout in a tropical city in Australia, Rheumatol Int, vol.36, issue.12, pp.1753-1761, 2016. ,
, Geneva: World Health Organization; 2010 (WHO Guidelines Approved by the Guidelines Review Committee), Global Recommendations on Physical Activity for Health
Trends and stabilization up to 2022 in overweight and obesity in Switzerland, Int J Environ Res Public Health, vol.7, issue.2, pp.460-72, 2010. ,
a Retrospective Analysis, Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, vol.33, issue.7, pp.1180-98, 2016. ,
Comprehensive dietary education in treated gout patients does not further improve serum urate, Intern Med J, vol.45, issue.2, pp.189-94, 2015. ,
Alcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case-crossover Study, Am J Med, vol.127, issue.4, pp.311-319, 2014. ,
3 (20) 65) Gout: Gout duration, years (mean±SD) Number of attacks/year (mean±SD) Presence of tophi, % (n) Serum uric acid, mg/dL (mean±SD) Urate-lowering therapy: % (n) Gout as reason for the consultation, Ann Rheum Dis, vol.71, issue.9, pp.1490-1495, 2012. ,
, NPM proposed by the physician: At least one NPM proposed, %(n) Number of NPM proposed by the physician
, SD: standard deviation; VAS: visual analogue scale, score between 0 and 100; NPM: nonpharmacological measures; * defined by a creatinine clearance <60ml/min calculated according to the Cockroft-Gault formula